A 43-year-old man with acute lymphoblastic leukemia was treated with three cycles of hyper-CVAD (hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) followed by allogeneic hematopoietic stem cell transplantation (HCT) from a sibling. Six months later, the patient presen
Acute eosinophilic pneumonia after allogeneic hematopoietic stem cell transplantation
β Scribed by Thierry Wagner; Nathalie Dhedin; Bruno Philippe; Elisabeth Rivaud; Jean Paul Vernant; Louis-Jean Couderc
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 79 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It is now well established that the efficacy of allogeneic hematopoietic stem cell transplant for eradicating a variety of hematologic malignancies is related to antitumor activity mediated by donor immune cells contained in the stem cell graft. Recent studies have provided fundamental insights into
## Abstract Charts and radiographs of 622 allogeneic hematopoietic stem cell transplant (HSCT) recipients, over a 20βyear period, were retrospectively reviewed for intracranial hemorrhage (ICH) following transplant. A total of 21 cases of ICH were identified (3.4%) including 15 cases of intraparenc
## Abstract __Pneumocystis carinii__ (__P. carinii__) is one of the major opportunistic pathogens responsible for hematopoietic stem cell transplantation (HSCT)βrelated pneumonias. Although trimethoprimβsulfamethoxazol (TMP/SMX) prophylaxis has been shown to prevent almost all __P. carinii__ infect